Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / schedule-f-mfn-pricing-methodology.docx
schedule-f-mfn-pricing-methodology.docx
Parties
Penterra Pharmaceuticals Corp
Meridian Korea Inc
Meridian Bio Australia Pty Ltd
Westmark Services Inc
If Westmark Services Inc
Dates
October 2, 2023
October 20, 2023
December 31, 2025
March 31, 2026
August 12, 2037
November 3, 2038
Amounts
$200,000,000
$500,000,000
$2,000,000
$15.00
$12.75
$11.50
$1.25
$250,000.00
Obligations
Capitalized terms used but not otherwise defined in this Schedule F shall have the meanings ascribed to such terms in the Agreement
Section 2: Definitions For purposes of this Schedule F, the following terms shall have the meanings set forth below: 2
The MFN Reference Price shall be determined on a per-unit basis (per tablet) for each dosage strength separately, such that a separate MFN Reference Price shall exist for the 25 mg dosage strength and for the 50 mg dosage strength
Where multiple pack sizes are sold in a Reference Market for the same dosage strength, the per-tablet Net Price for each such pack size shall be calculated and the lowest per-tablet Net Price across all Comparable Pack Sizes in all Reference Markets during the Reference Period shall constitute the MFN Reference Price for that dosage strength
Once a commercial sale has occurred in a Reference Market country, such country shall be included in all subsequent MFN Reference Price determinations
Net Price shall be calculated on a country-by-country basis, such that a separate Net Price determination shall be made for each country in which the Licensed Product is sold